Veretec are appointed as lead consultant for this state of the art redevelopment and refurbishment of the former Eli Lilly 19ha campus in Windlesham, Surrey for UCB Celltech.
- Location Surrey
- Status Pre-Construction Sector Health Care, Laboratory, Reuse
- Client UCB Celltech
- Services Project Delivery
- Design Architect Heatherwick Studio
The project ethos is to re-use and recycle which is manifested in the campus masterplan which retains the mix of existing buildings with new interventions to unify connectivity and promote collaboration through maximising opportunity, interactions and knowledge share.
The central hub building, using Cross Laminated Timber (CLT) and glulam, will unify the campus into a single building and support the execution of UCB’s research plan to develop innovative treatments for patients including gene therapies and translational medicine.
Works include extensive refurbishment/remodelling of the existing campus buildings by providing new state of the art laboratory facilities to reinforce UCB’s UK life sciences drive in developing innovative treatments to transform the lives of people living with severe diseases of the immune and central nervous system.
“The world-class project team would redevelop and redefine the space at Windlesham to provide us with a state-of-the-art working environment.”
Project Apple seeks to create a research and development (R&D) centre of excellence for the global pharmaceutical company UCB, relocating its UK based Early Discovery facilities from Slough to Windlesham.
Construction is due to start in 2022.
Click through the link to see a recent write up by the Architects Journal.